http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-009520-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68cd885c779fcd2dff63dcccdf94eaa8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-82 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-82 |
| filingDate | 2004-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14b169fc604fc23edf623b88af609f2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84bb58fca7c32ac69b5befe378d82744 |
| publicationDate | 2008-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-009520-B1 |
| titleOfInvention | COBASORB DIAGNOSTIC TEST FOR THE DETERMINATION OF COBALAMINE MALABSORPTION |
| abstract | The present invention relates to a new method called the COBASORB test, which can be used to determine the cause of cobalamin malabsorption in humans. The COBASORB test includes three separate tests (first, second and third tests) that can be performed separately, sequentially, or in any order and number. In the first test for administration, non-radioactive cobalamin is used, in the second test for administration, non-radioactive cobalamin and recombinant intrinsic factor are used, and in the third test for administration, recombinant haptocorrin saturated with cobalamin is used. All three tests include the analysis of changes in the concentration of cobalamin-saturated transcobalamin (holo-TC) and cobalamin-saturated haptocorrin (holo-HC) in the blood. The present invention also relates to kits for use in performing these methods. |
| priorityDate | 2003-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.